LCTX · Lineage Cell Therapeutics, Inc. · Executive Compensation
$1.00
+0.02 (+1.52%)
At close · Oct 23
View the 10-K filed Mar 5, 2026
Return incl. dividend (before tax)
Customer concentration
— top 2 customers 92% of revenue
2 customers — 92% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, the Company’s top two customers collectively represented 92% of the Company’s total revenue.”
One customer — 92% of revenue (the year ended December 31, 2024)
“For the year ended December 31, 2024, the Company's top single customer represented 92% of the Company’s total revenue.”
Market Cap
$252.91M
Shares
252.91M
Volume · Oct 23
1.15M
Avg daily vol (3M)
1.25M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Brian Culley | CEO | $1,349,913 |
| Brian M. Culley | Chief Executive Officer and Former Interim Chief Financial Officer | $1,349,913 |
| Chase C. Leavitt | Former General Counsel and Corporate Secretary | $752,952 |
| Brandi Roberts | Former Chief Financial Officer | $668,252 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Brandi Roberts | Former Chief Financial Officer | $947,963 |
| Brian M. Culley | Chief Executive Officer and Former Interim Chief Financial Officer | $772,742 |
| Brian Culley | CEO | $772,742 |
| Edward D. Wirth | III, M.D., Ph.D. Former Chief Medical Officer | $694,792 |
| Chase C. Leavitt | Former General Counsel and Corporate Secretary | $599,098 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Brian Culley | CEO | $2,862,707 |
| Brian M. Culley | Chief Executive Officer | $2,862,707 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Angus C. Russell | director | Appointed | 2023-09-07 |
| Michael H. Mulroy | director | Appointed | 2023-09-07 |
| Anula Jayasuriya | director | Appointed | 2023-09-07 |
| Alfred D. Kingsley | director | Appointed | 2023-09-07 |
| Neal C. Bradsher | director | Appointed | 2023-09-07 |
| Brian M. Culley | director | Appointed | 2023-09-07 |
| Don Bailey | director | Appointed | 2023-09-07 |
| Deborah Andrews | director | Appointed | 2023-09-07 |
| Dipti Amin | director | Appointed | 2023-09-07 |
| Jill A. Howe | Chief Financial Officer | Appointed | 2022-10-31 |
| Alexandra Hernandez | interim principal accounting officer | Appointed | 2022-07-07 |
| Brian M. Culley | interim Chief Financial Officer | Appointed | 2022-07-07 |
| Kevin L. Cook | Chief Financial Officer | Resigned | 2022-07-07 |
Leadership
- Brian M. Culley CFO, Board Member
- Jill A. Howe CFO, Board Member
- Alexandra Hernandez Chief Accounting Officer
- Angus C. Russell Board Member
- Anula Jayasuriya Board Member
- Anula Jayasuriya, M.D., Ph.D., M.B.A. Board Member
- Brian Culley Board Member
- Deborah Andrews Board Member
- Dipti Amin Board Member
- Don Bailey Board Member
- Dr. Dipti Amin Board Member
- George A. Samuel III Board Member
- Michael H. Mulroy Board Member
- Neal C. Bradsher Board Member
Key facts
CIK
876343
CUSIP
53566P109
13F (30d)
26 filings
26 filers
Visit website
Investor relations